Ziegler Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	$9.76M	Buy	133,567 +83,144	+165%	+$6.08M	0.37%	87
2023 Q4	$3.6M	Sell	50,423 -72,735	-59%	-$5.19M	0.16%	150
2023 Q3	$7.38M	Sell	123,158 -14,546	-11%	-$872K	0.3%	121
2023 Q2	$9.93M	Buy	137,704 +30,018	+28%	+$2.16M	0.38%	88
2023 Q1	$7.92M	Buy	+107,686	New	+$7.92M	0.31%	120